v3.26.1
Stockholders' Deficit (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Common Shares Issued During the Period

During the three months ended March 31, 2026, the Company issued shares of our common stock as follows (in thousands, except share data):

 

 

 

Three Months Ended March 31, 2026

 

 

 

 

 

 

 

 

 

 

Shares

 

 

Value

 

Common stock issued to Centre Lane Partners

 

 

2,922,566

 

 

$

14

 

Shares of common stock issued, net

 

 

2,922,566

 

 

$

14

 

 

During the three months ended March 31, 2025, the Company issued shares of our common stock as follows (in thousands, except share data):

 

 

 

Three Months Ended March 31, 2025

 

 

 

 

 

 

 

 

 

 

Shares

 

 

Value

 

Common stock issued for options exercised

 

 

50,400

 

 

$

2

 

Shares of common stock issued, net

 

 

50,400

 

 

$

2

 

 

Schedule Of Warrants

A summary of the Company’s warrants outstanding as of March 31, 2026 and December 31, 2025, is presented below.

 

March 31, 2026

 

 

 

 

 

 

 

 

 

Exercise Price

 

 

Number Outstanding

 

 

Gross Cash Proceeds (if exercised, in thousands)

 

$

0.65

 

 

 

-

 

 

$

-

 

$

0.75

 

 

 

-

 

 

$

-

 

$

1.00

 

 

 

175,000

 

 

$

175

 

 

 

 

 

175,000

 

 

$

175

 

 

December 31, 2025

 

 

 

 

 

 

 

 

 

Exercise Price

 

 

Number Outstanding

 

 

Gross Cash Proceeds (if exercised, in thousands)

 

$

0.65

 

 

 

-

 

 

$

-

 

$

0.75

 

 

 

-

 

 

$

-

 

$

1.00

 

 

 

175,000

 

 

$

175

 

 

 

 

 

175,000

 

 

$

175